These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 19428868)

  • 21. Characterization of the antibody response to the receptor binding domain of botulinum neurotoxin serotypes A and E.
    Baldwin MR; Tepp WH; Pier CL; Bradshaw M; Ho M; Wilson BA; Fritz RB; Johnson EA; Barbieri JT
    Infect Immun; 2005 Oct; 73(10):6998-7005. PubMed ID: 16177380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of the factors that govern the ability of therapeutic antibodies to provide postchallenge protection against botulinum toxin: a model for assessing postchallenge efficacy of medical countermeasures against agents of bioterrorism and biological warfare.
    Al-Saleem FH; Nasser Z; Olson RM; Cao L; Simpson LL
    J Pharmacol Exp Ther; 2011 Aug; 338(2):503-17. PubMed ID: 21586604
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of an Innovative in Vitro Potency Assay for Anti-Botulinum Antitoxins.
    Rosen O; Ozeri E; Barnea A; David AB; Zichel R
    Toxins (Basel); 2016 Sep; 8(10):. PubMed ID: 27669303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of antibodies against botulinum toxins.
    Sesardic D; Jones RG; Leung T; Alsop T; Tierney R
    Mov Disord; 2004 Mar; 19 Suppl 8():S85-91. PubMed ID: 15027059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fully Human Monoclonal Antibodies Effectively Neutralizing Botulinum Neurotoxin Serotype B.
    Matsumura T; Amatsu S; Misaki R; Yutani M; Du A; Kohda T; Fujiyama K; Ikuta K; Fujinaga Y
    Toxins (Basel); 2020 May; 12(5):. PubMed ID: 32392791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Production and evaluation of a recombinant subunit vaccine against botulinum neurotoxin serotype B using a 293E expression system.
    Yu Y; Shi D; Liu S; Gong ZW; Wang S; Sun Z
    Hum Vaccin Immunother; 2015; 11(2):468-73. PubMed ID: 25483668
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunological characterisation and immunoprotective efficacy of functional domain antigens of botulinum neurotoxin serotype A.
    Liu FJ; Shi DY; Mao YY; Xiong XH; Lu JS; Pang XB; Dong XJ; Yang ZX; Yu YZ
    Vaccine; 2020 Mar; 38(14):2978-2983. PubMed ID: 32113807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lectins from Triticum vulgaris and Limax flavus are universal antagonists of botulinum neurotoxin and tetanus toxin.
    Bakry N; Kamata Y; Simpson LL
    J Pharmacol Exp Ther; 1991 Sep; 258(3):830-6. PubMed ID: 1653841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the immunogenicity of botulinum toxin type A and the efficacy of A1 and A2 neurotoxins in animals with A1 toxin antibodies.
    Torii Y; Goto Y; Nakahira S; Kozaki S; Ginnaga A
    Toxicon; 2014 Jan; 77():114-20. PubMed ID: 24269688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deletion mutant comprising 198 residues of BoNT/A toxin receptor binding domain retained gt1b binding property but failed to induce protective antibody response in a mouse model.
    Singh MK; Gupta G; Boopathi M; Gupta P; Chauhan V; Tomar A; Singh L; Dhaked RK
    Protein Pept Lett; 2012 May; 19(5):530-7. PubMed ID: 22486648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Uptake of botulinum neurotoxin into cultured neurons.
    Keller JE; Cai F; Neale EA
    Biochemistry; 2004 Jan; 43(2):526-32. PubMed ID: 14717608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antigenic sites on the HN domain of botulinum neurotoxin A stimulate protective antibody responses against active toxin.
    Ayyar BV; Tajhya RB; Beeton C; Atassi MZ
    Sci Rep; 2015 Oct; 5():15776. PubMed ID: 26508475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization.
    Smith TJ; Lou J; Geren IN; Forsyth CM; Tsai R; Laporte SL; Tepp WH; Bradshaw M; Johnson EA; Smith LA; Marks JD
    Infect Immun; 2005 Sep; 73(9):5450-7. PubMed ID: 16113261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natural Compounds and Their Analogues as Potent Antidotes against the Most Poisonous Bacterial Toxin.
    Patel KB; Cai S; Adler M; Singh BK; Parmar VS; Singh BR
    Appl Environ Microbiol; 2018 Dec; 84(24):. PubMed ID: 30389764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies on the binding of botulinum toxin type A to the rat phrenic nerve-hemidiaphragm preparation.
    Simpson LL
    Neuropharmacology; 1974 Aug; 13(8):683-91. PubMed ID: 4444755
    [No Abstract]   [Full Text] [Related]  

  • 36. Study on the immunological heterogeneity of Clostridium botulinum B type toxin.
    Rymkiewicz D; Sawicki J; Brühl A
    Arch Immunol Ther Exp (Warsz); 1979; 27(5):709-14. PubMed ID: 398207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective potential of recombinant non-purified botulinum neurotoxin serotypes C and D.
    Moreira C; da Cunha CE; Moreira GM; Mendonça M; Salvarani FM; Moreira ÂN; Conceição FR
    Anaerobe; 2016 Aug; 40():58-62. PubMed ID: 27236078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and evaluation of candidate vaccine and antitoxin against botulinum neurotoxin serotype F.
    Yu YZ; Zhang SM; Ma Y; Zhu HQ; Wang WB; Du Y; Zhou XW; Wang RL; Wang S; Yu WY; Huang PT; Sun ZW
    Clin Immunol; 2010 Nov; 137(2):271-80. PubMed ID: 20696619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phrenic nerve-hemidiaphragm as a highly sensitive replacement assay for determination of functional botulinum toxin antibodies.
    Rasetti-Escargueil C; Liu Y; Rigsby P; Jones RG; Sesardic D
    Toxicon; 2011 Jun; 57(7-8):1008-16. PubMed ID: 21513727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of systemic handling in the pathophysiologic actions of botulinum toxin.
    Al-Saleem FH; Ancharski DM; Ravichandran E; Joshi SG; Singh AK; Gong Y; Simpson LL
    J Pharmacol Exp Ther; 2008 Sep; 326(3):856-63. PubMed ID: 18539649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.